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BACKGROUND: Anemia is frequently found in ulcerative colitis (UC) patients and assumed to be related to inflammatory process. Vitamin D3 (VD) 
is known to have anti-inflammatory and immunomodulatory 
effects. It also has the potential to be an alternative treatment 
of the inflammatory process that occurs at UC, however its 
mechanism has not been clearly established. This study 
aimed to assess the effect of VD on histopathology and 
hemoglobin levels in UC through its regulation in tumor 
necrosis factor (TNF)-α and interleukin (IL)-6. 
METHODS: Total samples of 24 mice were divided 
equally into Sham group, UC group, UC+VD group (given 
3% dextran sodium sulfate (DSS) followed by VD), and 
VD+UC group (given VD followed by 3% DSS). Mouse 
Colitis Histology Index (MCHI) was used to measure 
histopathological changes. Immunohistochemical staining 
was used to observe expression of TNF-α and IL-6 in colon. 
Evaluation of anemia was determined by hemoglobin levels.
RESULTS: Based on MCHI scores, significant epithelial 
damage was found in colon sample of UC group (8.25±3.05) 
compared to Sham (0.33±0.26), UC+VD (2.33±1.07), and 
VD+UC group (2.83±0.75) (p<0.05). Significant lower 
numbers of TNF-α were found in Sham (27.33±3.42), 
UC+VD (36.33±1.86), and VD+UC group (36.68±1.86) 
compared with UC group (44.66±4.87) (p<0.05). Significant 
less IL-6 expression was found in Sham (18.05±2.96), 
UC+VD (24.78±0.79), and VD+UC group (25.09±2.79) 
compared to UC group (38.85±3.51) (p<0.05). Differences 
in hemoglobin levels were significantly lower in UC group 
(11.85±0.97) compared to Sham (14.25±0.47), UC+VD 
(13.68±0.68), VD+UC group (13.52±1.07) (p<0.05). 
CONCLUSION: VD significantly reduced pro-
inflammatory cytokines, increased mucosal repair, and 
improved hemoglobin levels.
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Abstract
Introduction
Ulcerative colitis (UC) is characterized by diffuse 
inflammation of the colon and rectum mucosa.(1) Based 
on colonoscopy data from Saiful Anwar General Hospital 
in 2010-2014, 176 patients were diagnosed with UC or 
8.2% of the total colonoscopy patients.(2) A combination 
of genetic, environmental, and microbial factors causes 
colitis by disrupting immune system regulation in the 
form of changes in the balance of T helper cells to Th1 and 
Th17 compared to Th2.(3) If not treated properly, colitis 
can cause various complications such as anemia, as one 
of the most common extraintestinal complications.(4) The 
discharge of blood from the digestive tract continuously 
resulting in iron deficiency is what usually causes anemia 
in colitis.(5) Increased activity of pro-inflammatory 
cytokines such as tumor necrosis factor (TNF)-α and 
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interleukin (IL)-6 also can cause anemia in colitis. TNF-α 
increases ferritin production which reduces the amount of 
iron for erythropoiesis, and IL-6 initiates the formation 
of hepcidin as a negative regulator of iron absorption and 
iron release. These mechanisms disrupt the erythropoietin 
(EPO) signaling process and reduce the regulation of EPO 
receptors. Thereby EPO resistance is induced in erythroid 
progenitor cells.(5,6) Several studies have found low levels 
of vitamin D in colitis patients. Vitamin D deficiency plays 
a critical  role  in  the  severity  of  colitis  by  causing 
an increase in pro-inflammatory cytokines, decreased 
expression of tight junction, and bacterial clearance of 
intestinal epithelium.(7,8)
 Vitamin D refers to a group of fat-soluble secosteroids, 
and the primary compounds are vitamin D3 (cholecalciferol) 
and vitamin D2 (ergocalciferol). The biggest abundant 
source of vitamin D in our body is cholecalciferol synthesis 
in the skin through direct sun exposure. Ultraviolet-B 
(UVB) from the sun is absorbed by the skin that activates 
the synthesis of vitamin D.(9) The active form of vitamin D, 
vitamin D3 or calcitriol is known to take part in regulating 
various inflammatory cytokines so that an equilibrium can 
be achieved between pro-inflammatory cytokines (TNF-α, 
IL-6) and anti-inflammatory cytokines.(10-13) Then, 
with the controlled expression of various inflammatory 
cytokines, hepcidin formation can be inhibited to prevent 
the occurrence of anemia.(14)
Methods
The mice used in this study was obtained from Pusvetma, 
Surabaya, Indonesia. Treatment of animal models, 
immunohistochemistry (IHC) staining for TNF-α and IL-
6, hematoxylin-eosin (H&E) staining for measurement of 
epithelial damage, and measurement of hemoglobin level 
were all conducted at Faculty of Medicine, Universitas 
Brawijaya. Ethical clearance was obtained from the Ethics 
Committee of Faculty of Medicine, Brawijaya University, 
with number: 434/EC/KEPK/12/2017.
Treatment of Mice
This study used twenty-four 8 weeks old male Balb/c mice 
weighing 17-25 grams. The mice were randomly divided 
into 4 groups after 1 week of acclimatization. Distilled 
water was given to the sham group for 14 days. Colitis group 
was given 3% of dextran sodium sulfate (DSS) (Cat No. 
ab146569, Abcam, Cambridge, UK) for 7 days and followed 
by distilled water for 7 days. The first treatment group 
(UC+VD) was given 3% of DSS for 7 days and followed 
by vitamin D3 (Oscal, Calcitriol, Dankos Farma, Jakarta, 
Indonesia) at a dose of 0.2 ug/25 g/day via intragastric for 
7 days. The second treatment group (VD+UC) was given 
vitamin D3 at a dose of 0.2 ug/25 g/day via intragastric for 
7 days and followed by 3% of DSS for 7 days. After DSS 
induction and vitamin D3 administration in the treatment 
group were completed, all mice were dissected to collect 
blood samples and colonic tissue. The colitis condition was 
confirmed by the epithelial damage in histopathological 
colon after dissection. The distal colon was taken to make 
paraffin block and sliced using a microtome. Last, H&E and 
IHC staining were observed using the blind method.
Histopathological Analysis
A 5-mm distal colonic portion was formed in paraffin and 
H&E stain. The Mouse Colitis Histology Index (MCHI) 
score was used to measure colonic epithelial damage. 
MCHI = (1x Goblet cells disappear) + (2 x crypt density) + 
(2 x crypt hyperplasia) + (3 x submucosal infiltration).(15)
Hemoglobin Analysis
Blood samples were taken and were diluted in the WBC 
chamber then measured by Spectrophotometry, through 
optical pathways in the white blood cell (WBC) room. 
Then the reading was carried out at λ 532 nm with a 
spectrophotometer using the Hematology Analyzer ABX 
Micro 60 (Horiba ABX SAS, Irvine, California, USA), 
which can be used to analyze hemoglobin levels in mice. 
Hemoglobin  levels  were  expressed  in  grams  per  deciliter 
(g/dL).
IHC Staining of TNF Alpha and IL-6 Expression
Colon parts were fixed in neutral buffer formalin and 
embedded in paraffin. Then, they were deparaffinized, 
as well as sequentially rehydrated using xylol, absolute 
ethanol, 90% ethanol, 80% ethanol, 70% ethanol, sterile 
distillated aqua, 3% H2O2, and blocking buffer. The parts 
were examined with Rabbit polyclonal TNF-α (Cat No. bs-
2081R, Bioss, Woburn, USA) and IL-6 (Cat No. bs-0782R, 
Bioss, Woburn, USA), then incubated overnight at 4oC. After 
incubation, they were thoroughly washed with phosphate 
buffer saline (PBS) for 5 minutes and repeated three times. 
Subsequently, the colon parts were incubated with secondary 
antibody at room temperature for 60 minutes, then with 
horseradish peroxidase at room temperature for 40 minutes. 
Reaction products were visualized by diaminobenzidine 
(Nichirei Bioscience Inc, Tokyo, Japan) and hematoxylin. 
Then, cells expressing TNF-α and IL-6 in the form of 
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cells with a flat, brownish core were observed under the 
microscope in 20 fields of view with 400x magnification. 
Last, the mean scores were collected.
Statistical Analysis
Data were expressed as mean±standard error of the mean 
(SEM). Comparisons between the 4 groups (Sham, UC, 
UC+VD, and VD+UC) were analyzed using analysis 
of variance (ANOVA) test. A comparison between two 
different groups was carried out using the Post Hoc LSD 
test. Kruskal-Wallis and Post Hoc Mann-Whitney tests 
were used for abnormal and non-homogeneous data. The 
p-values<0.05 were considered statistically significant. 
All statistical analyses were conducted using IBM SPSS 
software ver. 23.0 (IBM Co., Armonk, NY, USA).
Results
Vitamin D3 and Reduction of Epithelial Damage
The mice model of colitis was induced by 3% of DSS 
through drinking water. Epithelial damage increased in the 
UC group compared to other groups (Figure 1). In Figure 
1, two observers found significant epithelial damage in 
A B
C D
Figure 1. Light microscopy observation of the colon tissue samples of mice following haematoxylin and eosin staining. Black arrow: 
goblet cell;  Blue arrow: decreased crypte density; Red arrow: hyperplasia crypte; Yellow arrow: leukocytes infiltration. Black bar: 100µm.
colon samples of UC group, marked by the loss of goblet 
cells, decreased cryptic density, hyperplasia, and leukocytes 
infiltration into sub-mucosa in the UC colon. Comparisons 
of MCHI scores of the samples showed significant increases 
in UC (8.25±3.05) compared to sham (0.33±0.26), UC 
compared to UC+VD (2.33±1.07), and UC compared to 
VD+UC (2.83±0.75) (p<0.05). However, there was no 
significant difference found between Sham, UC+VD and 
VD+UC groups (p>0.05).
Hemoglobin Level 
This research evaluated colitis-induced anemia to determine 
the potential of vitamin D3 in effectively increasing 
hemoglobin levels. The mean hemoglobin levels of mice 
after the treatment were measured (g/dL) (Table 1). The 
levels of hemoglobin in UC group (11.85±0.97) decreased 
compared to other groups. ANOVA test results showed 
significant differences between each treatment in the 
parameter measured at α=0.05. Table 2 showed that UC+VD 
group (13.68±0.68) and VD+UC group (13.52±1.07) 
had a significant increase in hemoglobin effect at a 95% 
confidence level compared to UC group. There was no 
significant difference found between Sham, UC+VD and 
VD+UC groups (p>0.05).
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Sham UC UC+VD VD+UC
Sham (14.25±0.47) - 0.000* 0.252 0.143 0.000
UC (11.85±0.97) 0.000* - 0.001* 0.002*
UC+VD (13.68±0.68) 0.252 0.001* - 0.732
VD+UC (13.52±1.07) 0.143 0.002* 0.732 -
Post Hoc LSD
p -value#Groups
Table 1. Multiple comparisons of hemoglobin levels.
#Significancy was tested with ANOVA (p<0.05).
Vitamin D3 and TNF-α Expression
TNF-α (cell/field of view) expression of colonic samples 
after IHC staining (Figure 2) in Sham (27.33±3.42), UC+VD 
(36.33±1.86), and VD+UC (38.68±3.68) groups showed 
a significant smaller number of TNF-α cells compared to 
UC (44.66±4.87) (p<0.05). Meanwhile, there were no 
significant differences between the UC+VD and VD+UC 
groups (p> 0.05) (Table 2).
A B
C D
Figure 2. Results of immunohistochemistry staining to observe numbers of cells that express TNF-α. Yellow arrow: TNF-α+ cells 
(cells with a flat, brownish core). Black bar: 20µm. 
Sham UC UC+VD VD+UC
Sham (27.33±3.42) - 0.002* 0.002* 0.002* 0.000
UC (44.66±4.87) 0.002* - 0.002* 0.041*
UC+VD (36.33±1.86) 0.002* 0.002* - 0.589
VD+UC (38.68±3.68) 0.002* 0.002* 0.589 -
Groups
Mann Whitney
p-value #
#Significancy was tested with Kruskal Wallis (p<0.05).
Table 2. Multiple comparisons of TNF-a expression.
Vitamin D3 and IL-6 Expression
As shown in Figure 3, the number of cells expressing 
IL-6 (cells/field of view) decreased significantly in 
Sham (18.01±2.96), UC+VD (24.78±0.79), and VD+UC 
(25.09±2.79) groups compared to UC group (38.85±3.51) 
(p<0.05). Meanwhile, there was no significant difference 
between the UC+VD group and VD+UC group (p>0.05) 
(Table 3).
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Discussion
 At present, various treatments do not meet the 
full remission of the ulcerative condition and cause 
complications like anemia. Anemia is frequently found 
in patients at the time of diagnosis and correlates with 
the severity of the disease.(16,17) Anemia in colitis can 
occur as a consequence of impaired absorption of iron, 
continuous blood loss in the acute phase, or even both.(18) 
As shown in this study, we found significant differences 
in hemoglobin levels among colitis mice compared to the 
Sham group. Hemoglobin levels increased with vitamin D3 
administration, which suggested that vitamin D3 played a 
role in preventing or improving anemia as a complication of 
colitis.
 Vitamin D3 is known as an immunomodulation 
agent in homeostasis and inflammation disease. Vitamin 
D3 reduced the expression of TNF-α and IL-6 colon in 
this study. As previously known, vitamin D3 can decrease 
the activation of NF-κB in a vitamin D receptor (VDR)-
A B
DC
Figure 3. Results of immunohistochemistry staining to observed number of cells that express IL-6. Yellow arrow: IL-6+ cells (cells 
with a flat, brownish core). Black bar: 20µm.
Sham UC UC+VD VD+UC
Sham (18.05±2.96) - 0.002* 0.002* 0.009* 0.000
UC (38.85±3.51) 0.002* - 0.002* 0.002*
UC+VD (24.78 0.79) 0.002* 0.002* - 0.937
VD+UC (25.09±2.79) 0.009* 0.002* 0.937 -
Mann Whitney
p-value #Groups
Table 3. Multiple comparisons of  IL-6 expression.
#Significancy was tested with Kruskal Wallis (p<0.05).
dependent manner. Vitamin D also blocks the TNF-α-
induced NF-κB activation. The deletion of VDR also 
ameliorates the regulation of inflammation by reducing IκBα 
production. IκBα inhibits the NF-κB activity by preventing 
its translocation into the nucleus.(19,20) Then, the levels of 
IL-6 may affect hemoglobin levels by increasing hepcidin 
production. Increased hepcidin production is inversely 
correlated with circulating iron levels. It binds ferroportin, 
the iron exporter, to prevent the release of iron from 
enterocyte into circulation.(18) This can be one of the 
underlying mechanisms of anemia in colitis because IL-6 
production increases significantly and may lead to iron 
deficiency.
 Previous studies have shown that vitamin D 
supplementation in clinical trials of UC patients significantly 
improved patients' quality of life, based on Inflammatory 
Bowel Disease Questionnaire-9 (IBDQ-9) and Simple 
Clinical Colitis Activity Index Questionnaire (SSCAIQ) 
questionnaires.(21) In this study, vitamin D3 administration 
improved the mucosal improvement, which was evaluated 
by MCHI score. This scoring system is a newly developed 
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tool to evaluate mucosal damage and is claimed to be as 
reliable as endoscopic evaluation in pre-clinical studies.(15) 
The finding of increased mucosal improvement in this study 
indicated the role of vitamin D3 in preventing or treating 
anemia in colitis, as it reduced the possibility of continuous 
blood loss. Blood loss itself was included in the calculation 
of Mayo score to determine the severity of the disease with 
other endoscopic and clinical scales used.(22)
 This study would reveal that there are other benefits 
of vitamin D3 administration to anemia, as one of the most 
frequent complications of ulcerative colitis. However, 
further research is required to understand the mechanism 
of vitamin D3 in the regulation of hepcidin production to 
increase hemoglobin levels. Further evaluation is needed to 
determine vitamin D3 levels in circulation, its toxicity, and 
other aspects to determine the most beneficial pathway as 
a therapeutic or preventive target in the development and 
severity of ulcerative colitis.
Conclusion
Before and after the colitis induction, vitamin D3 
administration significantly reduced the expression of 
pro-inflammatory cytokines, especially TNF-α and IL-6. 
This treatment also improved the mucosal repair process, 
as showed in the histology studies and observed with the 
MCHI score. Moreover, vitamin D3 administration in this 
study improved anemia condition in UC, which was proved 
by significantly higher hemoglobin levels in the treatment 
groups. However, all these benefits of vitamin D3 still 
require further research to determine its therapeutic window 
and toxicity.
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